Abstract
There are many patents for magnetic nanoparticles as tumor magnetic resonance imaging enhancers, but the gadolinium complexes commonly used in the clinic are difficult to target the diseased tissues, while nanoliposomes are ideal carriers for anti-tumor drugs.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Clinical Microbiology and Biochemical Technology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
